Table 3 Secondary analysis of side effects and pill counts
| Â | Â | Side effects | Adherence | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Â | Number alive in sample | Number with side effects recorded | Percent with adverse side effects | 95% Confidence interval | Number alive and on 1st line in sample | Number with PC recorded | Percent with good adherence | 95% Confidence interval | ||
Site 1 | 49 | 47 | 2.1% | 0.1% | 11.3% | 49 | 46 | 69.6% | 54.2% | 82.3% |
Site 2 | 42 | 26 | 7.7% | 0.9% | 25.1% | 39 | 29 | 89.7% | 72.6% | 97.8% |
Site 3 | 47 | 41 | 14.6% | 5.6% | 29.2% | 43 | 39 | 94.9% | 82.7% | 99.4% |
Site 4 | 59 | 55 | 1.8% | 0.0% | 9.7% | 57 | 47 | 87.2% | 74.3% | 95.2% |
Site 5 | 58 | 55 | 0.0% | 0.0% | 6.5% | 56 | 53 | 77.4% | 63.8% | 87.7% |
Site 6 | 45 | 36 | 5.6% | 0.7% | 18.7% | 39 | 31 | 80.6% | 62.5% | 92.5% |
Site 7 | 44 | 44 | 0.0% | 0.0% | 8.0% | 44 | 43 | 100.0% | 91.8% | 100.0% |
Site 8 | 32 | 28 | 7.1% | 0.9% | 23.5% | 30 | 28 | 85.7% | 67.3% | 96.0% |
Site 9 | 44 | 33 | 15.2% | 5.1% | 31.9% | 32 | 13 | 92.3% | 64.0% | 99.8% |
Site 10 | 39 | 38 | 2.6% | 0.1% | 13.8% | 39 | 39 | 74.4% | 57.9% | 87.0% |
Site 11 | 31 | 27 | 3.7% | 0.1% | 19.0% | 30 | 26 | 92.3% | 74.9% | 99.1% |
Site 12 | 73 | 69 | 2.9% | 0.4% | 10.1% | 70 | 65 | 67.7% | 54.9% | 78.8% |
Site 13 | 41 | 34 | 2.9% | 0.1% | 15.3% | 38 | 33 | 84.8% | 68.1% | 94.9% |
Site 14 | 74 | 59 | 0.0% | 0.0% | 6.1% | 65 | 56 | 85.7% | 73.8% | 93.6% |
Site 15 | 57 | 49 | 26.5% | 14.9% | 41.1% | 39 | 32 | 78.1% | 60.0% | 90.7% |
Site 16 | 48 | 45 | 6.7% | 1.4% | 18.3% | 41 | 34 | 76.5% | 58.8% | 89.3% |
Total | Â | Â | 7.2% | 4.8% | 9.6% | Â | Â | 86.3% | 82.8% | 89.8% |